Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Despite notable therapeutic advances in the last decades, 30%–40% of affected patients develop relapsed or refractory disease that frequently precludes an infamous outcome. With the advent of new therapeutic optio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosquera Orgueira, Adrián, Díaz Arías, Jose Ángel, Cid López, Miguel, Peleteiro Raíndo, Andrés, López García, Alberto, Abal García, Rosanna, González Pérez, Marta Sonia, Antelo Rodríguez, Beatriz, Aliste Santos, Carlos, Pérez Encinas, Manuel Mateo, Fraga Rodríguez, Máximo Francisco, Bello López, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984321/
https://www.ncbi.nlm.nih.gov/pubmed/35392483
http://dx.doi.org/10.1097/HS9.0000000000000706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984321/
https://www.ncbi.nlm.nih.gov/pubmed/35392483
http://dx.doi.org/10.1097/HS9.0000000000000706

Ejemplares similares